Search results

The paper aims to describe and discuss the establishment of customer care centres in Sweden with particular concerns about information security.

The paper is part of a series about information security and the approach is to study the subject within an organisation and initially to understand how it works.

An effective way was found to embrace as many factors as possible by using a theory that contains the characteristics of the organisation. It was found that a combination of general systems theory and classic information systems theory was very successful.

The new systems and new structure within the Corporation of Swedish Pharmacies (Apotekes) will in future create better conditions for customers and the opportunity to have products delivered at home or by collection from the centres.

Describes new and ongoing developments aimed at improving customer care and demonstrates the application of system theory to the resulting organisation and implementation.

This study investigates the relationship between the development of academic spin-offs (ASOs) and the type of financing involved, by considering three research questions: How do ASOs differ in terms of financing? To what extent and for what reasons do ASOs differ in their financing? How do business and growth models dictate the selection of different sorts of financing arrangement?

The study employs a grounded-theory, qualitative approach based on 39 Spanish ASOs.

There is a heterogeneity of ASO financing, and the selection of financial resources is related to the business and growth model of the ASO. Furthermore, there are some critical junctures for financing within each group of ASOs.

The study advances the understanding of the determinants of ASOs, specifically with respect to financing, business models and growth orientation. The Spanish context used here may not permit the global generalisation of the results; nevertheless, this study is a response to calls to consider the effect of regional context on ASOs.

Knowing the heterogeneity of ASOs in terms of financing and how business and growth models determines the selection of distinct financing sources help financial planning, investment decisions and the design of programmes and policies, which can be relevant for both ASOs and their stakeholders (investors, universities and governments).

This study provides a comprehensive view of ASO financing, confirming a heterogeneity, not only in terms of financing but also in some critical junctures that presage a change from one type of financing to another.

Despite the importance of high-technology firms to the global economy, relatively little is known about factors contributing to these firms’ long-run growth. We examine these factors using a unique longitudinal dataset combining two waves of detailed surveys of 345 UK high-tech firms with performance data from UK official datasets. Overall we conclude that the early strategic decisions made by firms have long-run impacts on their subsequent growth, and we suggest that policy measures targeted at shortfalls faced by these firms may have positive long-term consequences.

The purpose of this paper is to develop a perspective on what is “salient” or critical to the discipline of healthcare marketing by analyzing and contrasting the consumer (or patient) perspective with the institutional (or organizational) perspective. This “salience issue” is complicated by the structural problems in healthcare such as societal service systems, advances in medical technology, and the escalating costs of care. Reviewing selected studies, the paper examines how consumers face increasingly difficult health choices.

The paper examines the different priorities and goals for marketing that are implied by both patient and organizational perspectives in healthcare, focusing primarily on the excesses of the more “market‐based” US healthcare system.

Healthcare organizations need to better utilize marketing tools to inform consumers and assist their healthcare decisions. This effort needs to be balanced by healthcare organizations that can support the demand to improve quality and increase accessibility of care.

The perspective on the consumer (or patient) often becomes clouded amid the operation of increasingly complex and convoluted healthcare systems. A new perspective on healthcare marketing needs to be considered. Greater consumer access to healthcare information could improve patient decision making. To accomplish this, greater institutional diffusion of evidence‐based healthcare practices is needed to improve organizational performance.

The purpose of this paper is to show that performance data use could be promoted with a better understanding of the type of indicators that are important to different stakeholders. This study explored patient, nurse, physician and manager preferences for cancer care quality indicators.

Interviews were held with 30 stakeholders between March and June 2004. They were asked to describe how they would use a cancer “report card”, and which indicators they would want reported. Transcripts were reviewed using qualitative analysis.

Role (patient, nurse, physician, manager) influenced preferences and perceived use of performance data. Patients and physicians were more skeptical than nurses and managers; patients and managers expressed some preferences distinct from nurses and physicians; and patients and nurses interpreted indicators more broadly than physicians and managers. All groups preferred technical process over outcome or interpersonal process indicators.

Expressed views are not directly applicable beyond this setting, or to the general public but findings are congruent with attitudes to performance data for other conditions, and serve as a conceptual basis for further study.

Strategies for maximizing the relevance of performance reports might include technical process indicators, selection by multi‐stakeholder deliberation, information that facilitates information application and customizable report interfaces.

Performance data preferences have not been thoroughly examined, particularly in the context of cancer care. Factors were identified that influence stakeholder views of performance data, and this framework could be used to confirm findings among larger and different populations.